Breast Cancer Is The Latest Disease Allegedly Caused By Zantac

The family of a deceased Florida woman thinks their mother died of cancer caused by taking Zantac

Monday, May 18, 2020 - The number of lawsuits against Sanofi, the maker Zantac, the world's best-selling heartburn medication, continues to grow as does the variety of the types of cancer that plaintiffs allege it has caused them. Most recently the estate of a Florida woman who died in May of 2018, filed a complaint against Sanofi and others alleging that the woman's three-decades-long love affair with the drug caused her to develop breast cancer. Others have filed suit claiming Zantac caused their stomach, bladder, esophageal, prostate, gastrointestinal, and now breast cancer. The deceased woman's son alleges that his mother took the anti-heartburn medication regularly for more than 30 years to fight acid indigestion. Zantac cancer lawsuits are handled by top national attorneys with a winning track record against big pharmaceutical companies and offer a free consultation before filing a lawsuit claim.

AboutLawsuits.com reports on the crux of the suit filed on May 12, 2020, in the US District Court for Southern Florida. "The lawsuit names various manufacturers of prescription and over-the-counter Zantac as defendants, including Boehringer Ingelheim, Sanofi US Services, Chattem, Pfizer, and GlaxoSmithKline, indicating the drug makers have known for years that the active pharmaceutical ingredient ranitidine converts to high levels of the cancer-causing chemical N-Nitrosodimethylamine (NDMA)." If you or a deceased loved had taken Zantac regularly over many years and have suffered from cancer of the stomach, bladder, esophageal, prostate, gastrointestinal, or breast cancer you may qualify to file a claim against Sanofi or other ranitidine manufacturers. More importantly, if you have taken Zantac you should seek medical attention as the anti-heartburn medicine is accused of causing life-threatening cancer, and delaying treatment could make managing the disease more difficult. Diagnosing Zantac cancer early is essential in catching cancer before it spreads and is impossible to stop.

According to About Lawsuits, the family of the decease only recently put two and two together when they discovered that scientific tests of Zantac by online testing pharmacy Vaisure uncovered alarmingly excessive levels of the cancer-causing chemical N-Nitrosodimethylamine (NDMA) had developed in the medication. Reasons being investigated as the cause of the spike in the carcinogen are thought to be storing the medication at higher than average room temperatures and also when ranitidine mixes with the common meat preservative nitrate in the stomach, ironically very often the reason one reaches for the Zantac after eating in the first place. Other reasons that are being explored for ranitidine's instability are "side reactions from drug syntheses, the breakdown of unstable drug compounds, and contamination from recycled solvents used in manufacturing," according to Chemical & Engineering News (CE&S).

This and other lawsuits against the makers of ranitidine heartburn and acid reflux medication were triggered when Valisure reported its finding of over 200 times the acceptable levels of ranitidine to the US Food and Drug Administration. Small increases in ranitidine can be significant as the chemical bioaccumulates in the tissue of those who take it regularly for a long time. Sanofi reacted by voluntarily withdrawing Zantac from the market pending the results of further scientific testing. The FDA initially failed to venture an opinion on the company's voluntary recall however, the agency recently announced that it was suggesting that manufacturers of ranitidine recall all lots and types of these medications, according to CE&S.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.